Navigation Links
L3 Healthcare’s Clinical Trials Division Becomes Certified Designer for iMedNet eClinical and Electronic Data Management Software
Date:4/25/2017

L3 Clinical Trials, the Clinical Research Organization (CRO) division of L3 Healthcare, is pleased to announce the company is now a certified iMedNet eClinical and Electronic Data Capture software designer for clinical trial data management. The iMedNet software certification enables the company’s clinical research team to build, customize and manage clinical trial data capture and databases for clients. In completing this certification, L3 Clinical Trials, continues to provide an integrated and comprehensive suite of services that can support an entire clinical trial program: from study concept to data analysis, reporting, and site level payments.

“A fully integrated clinical research organization that has the expertise, know-how and streamlined approach helps customers conduct clinical trials efficiently and cost-effectively,” said Chermaen Lindberg, Partner at L3 Healthcare. “Our certification allows us to manage all aspects of a clinical trial, obviating the need to utilize additional data management resources, apply add-ons, or subcontract with 3rd party data management vendors.” By eliminating these common but unnecessary complexities, L3 Clinical Trials is uniquely positioned to provide clients with premium services at the most affordable industry rates.

The L3 Clinical Trials’ business model is based on providing start-ups and mid-size in vitro diagnostic (IVD) and medical device companies with highly experienced resources that intuitively and effectively function as part of their clients’ project teams. In obtaining the certification through iMedNet, L3 Clinical Trials reinforces its integrated and collaborative approach with consistent staff resources throughout the process, fostering the best possible environment and identifying cost-effective clinical trial solutions.

“We pursued iMedNet certification so that we can deliver several unique and time-saving steps for our sites and our sponsors, such as the ability to access and use the system on multiple platforms and provide electronic-entry adjudication capability,” said Jane Edwards, VP Clinical Research at L3 Healthcare. “By streamlining the process and providing the most advanced technology, we can provide yet another solution for simplifying the integration of electronic data capture (EDC) into clinical studies. This improves workflow for clinicians and research coordinators while helping contain costs.”

About L3 Healthcare
L3 Healthcare, founded by IVD and medical device professionals, provides proven pre- and post-market expertise and resources dedicated to assisting organizations with generating clinical evidence, establishing clinical value and increasing market adoption in the global marketplace. L3 Clinical Trials, a division of L3 Healthcare, focuses its services on devising and executing clinical trials through streamlined processes, staff, technology and its vast key opinion leader and research network in the biotech and life science industries. The L3 Clinical Trials team understands the importance of strategically approaching clinical trials and go-to-market projects in environments with limited funds and resources, and seamlessly fills in the gaps where needed to achieve the desired goals. L3 specializes in key disease states and global markets that help provide value and a distinct edge for its clients. For more information, visit http://www.L3clinicaltrials.com.

About iMedNet
MedNet Solutions is a leading healthcare technology company specializing in electronic data solutions designed for the global life sciences community. MedNet’s proven, flexible and easy-to-use cloud-based eClinical systems dramatically improve the efficiency of clinical studies and registries of all types and sizes. Beyond simply electronic data capture (EDC), MedNet’s solutions deliver the tools and dashboards required to expertly manage all aspects of clinical research. Since 2001, pharmaceutical, medical device, biotechnology and Contract Research Organizations (CROs) around the world have trusted MedNet to consistently deliver the technology innovation, experience and reliability they need for success. For more information, please visit http://www.mednetsolutions.com/

Read the full story at http://www.prweb.com/releases/2017/04/prweb14269186.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Parallel6 Named One of the 2017 Top 10 eClinical Trial Management Solution Providers by Pharma Tech Outlook
2. Nobilis Therapeutics Announces Completion of Landmark NBTX-001 Clinical Trial in 81 Patients with Panic Disorder
3. First Published Clinical Study Successfully Uses Precision Medicine To Predict Prescription Opioid Abuse
4. Multi-Center Clinical Study Confirms Decreased Levels of Procalcitonin as an Independent Predictor of Mortality in Patients with Severe Sepsis and Septic Shock
5. Benchmark Research/VaxCorps Named one of the Top Clinical Research Networks at ViE Awards
6. SimpleTrials Selected as a Top 10 eClinical Trial Management Solution Provider by Pharma Tech Outlook
7. Human Gene Therapy publishes review of randomized clinical trials of gene transfer for heart failure with reduced ejection fraction
8. 2-Day Seminar FDAs GMP Expectations for Phase I and First-in-Man Clinical Trials by Ex-FDA Official (Tampa, FL, United States - May 18-19, 2017) - Research and Markets
9. Keystone Nano Announces Start Of Clinical Testing Of Ceramide NanoLiposome For The Improved Treatment Of Cancer
10. Research Centers of America Adopts Verified Clinical Trials Biometrics Research Subject Database Registry to Prevent Duplicate Enrollment in Clinical Trials
11. Nektar Therapeutics Presents New Preclinical Data for its Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... August 16, 2017 , ... Today, 3Bar Biologics Inc ... $2M in funding from an impressive group of investors, including Rev1 Ventures, Maumee ... With this investment, 3Bar is broadening availability of its groundbreaking offering that uses ...
(Date:8/15/2017)... ... ... Kapstone Medical is proud to announce that it has reached a ... develop and safeguard their latest innovations. The company has grown from a boutique ... in the United States and around the world. , Company Founder and President, ...
(Date:8/15/2017)... ... August 15, 2017 , ... The Conference Forum ... 360° (IO360°) programming through a series of upcoming panels and events. The partnership culminates ... at The Roosevelt Hotel in New York City. , “With our experience in producing ...
(Date:8/14/2017)... ... , ... The Conference Forum has confirmed the one-day agenda for ... 6, 2017 at the Marriott Copley Place in Boston, MA. , Returning as program ... Strategy, Pfizer Innovative Research Lab, Pfizer, who leads 19 industry speakers in discussing how ...
Breaking Biology Technology:
(Date:5/16/2017)... DALLAS , May 16, 2017   ... for health organizations, and MD EMR Systems ... certified development partner for GE, have established a ... Patient Portal product and the GE Centricity™ products, ... Centricity EMR. These new integrations ...
(Date:4/17/2017)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company"), ... Report on Form 10-K on Thursday April 13, 2017 with the ... The ... section of the Company,s website at http://www.nxt-id.com  under "SEC Filings," ... 2016 Year Highlights: Acquisition of ...
(Date:4/11/2017)... , April 11, 2017 No two ... researchers at the New York University Tandon School ... Engineering have found that partial similarities between prints ... used in mobile phones and other electronic devices ... The vulnerability lies in the fact that ...
Breaking Biology News(10 mins):